We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Oncology Leaders Sketch Out New Trial Designs for Accelerated Approvals
FDA Oncology Leaders Sketch Out New Trial Designs for Accelerated Approvals
FDA leaders in oncology want sponsors seeking accelerated approval (AA) for cancer drugs to use new trial designs that will make the whole process more efficient and ultimately safer for patients.